Epigenetic loss of maspin expression was observed in the advanced and chemo-refractory cancers [21, 22], supporting the anti-metastatic and pro-apoptotic properties of maspin against tumor progression and chemoresistance. This evidence concerns the gene SERPINB5 and cancer.